Search research articles
Contact Us
Filters
Showing results (211-220 of 256) with videos related to
Page
of 26
Sort By:
Journal of Pediatric Surgery
|
September 22, 2000
Childhood carcinoid tumors: the St Jude Children's Research Hospital experience
S L Spunt, C B Pratt, B N Rao, et al.
Cancer
|
January 15, 1994
Paratesticular rhabdomyosarcoma: delayed effects of multimodality therapy and implications for current management
L L Hughes, M J Baruzzi, R C Ribeiro, et al.
Journal of Pediatric Surgery
|
December 1, 1983
Limb salvage procedures for children with osteosarcoma: an alternative to amputation
B N Rao, J E Champion, C B Pratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1995
Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease
O Beaty, M M Hudson, C Greenwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1999
Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias
M H Woo, M V Relling, D S Sonnichsen, et al.
Cancer
|
November 1, 1994
Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors
C B Pratt, W H Meyer, N Howlett, et al.
Cancer Treatment Reports
|
June 1, 1986
Phase I study of ICRF-187 in pediatric cancer patients and comparison of its pharmacokinetics in children and adults
J S Holcenberg, K D Tutsch, R H Earhart, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity
M P Goren, A A Forastiere, R K Wright, et al.
Cancer
|
June 20, 2001
Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma
W E Reddick, S Wang, X Xiong, et al.
Journal of Pediatric Hematology/Oncology
|
August 13, 1999
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy
M J Coppes, R Yanofsky, S Pritchard, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 256) with videos related to
Sort By:
Page
of 26
Journal of Pediatric Surgery
|
September 22, 2000
Childhood carcinoid tumors: the St Jude Children's Research Hospital experience
S L Spunt, C B Pratt, B N Rao, et al.
Cancer
|
January 15, 1994
Paratesticular rhabdomyosarcoma: delayed effects of multimodality therapy and implications for current management
L L Hughes, M J Baruzzi, R C Ribeiro, et al.
Journal of Pediatric Surgery
|
December 1, 1983
Limb salvage procedures for children with osteosarcoma: an alternative to amputation
B N Rao, J E Champion, C B Pratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1995
Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease
O Beaty, M M Hudson, C Greenwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1999
Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias
M H Woo, M V Relling, D S Sonnichsen, et al.
Cancer
|
November 1, 1994
Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors
C B Pratt, W H Meyer, N Howlett, et al.
Cancer Treatment Reports
|
June 1, 1986
Phase I study of ICRF-187 in pediatric cancer patients and comparison of its pharmacokinetics in children and adults
J S Holcenberg, K D Tutsch, R H Earhart, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity
M P Goren, A A Forastiere, R K Wright, et al.
Cancer
|
June 20, 2001
Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma
W E Reddick, S Wang, X Xiong, et al.
Journal of Pediatric Hematology/Oncology
|
August 13, 1999
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy
M J Coppes, R Yanofsky, S Pritchard, et al.
Page
of 26